Results 61 to 70 of about 9,135 (190)

Osteoprotegerin is a new regulator of inflammation and angiogenesis in proliferative diabetic retinopathy [PDF]

open access: yes, 2003
Osteoprotegerin (OPG) is a novel regulator of endothelial cell function, angiogenesis, and vasculogenesis. We correlated expression levels of OPG with those of the angiogenic and inflammatory factors vascular endothelial growth factor (VEGF) and monocyte
Abu El-Asrar, Ahmed M   +11 more
core   +3 more sources

Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model.

open access: yesPLoS ONE, 2020
Proliferative vitreoretinopathy (PVR) is a progressive disease that develops in a subset of patients who undergo surgery for retinal detachment repair, and results in significant vision loss.
Alison M Heffer   +5 more
doaj   +1 more source

Personalized Medicine in Ocular Fibrosis: Myth or Future Biomarkers [PDF]

open access: yes, 2016
SIGNIFICANCE: Fibrosis-related events play a part in the pathogenesis or failure of treatment of virtually all the blinding diseases around the world, and also account for over 40% of all deaths.
Khaw, PT, Yu-Wai-Man, C
core   +1 more source

Therapeutic Interventions against Inflammatory and Angiogenic Mediators in Proliferative Diabetic Retinopathy [PDF]

open access: yes, 2012
The global prevalence of diabetes is estimated to be 336 million people, with diabetic complications contributing to significant worldwide morbidity and mortality.
Gologorsky, Daniel   +2 more
core   +3 more sources

Hybrid wide-angle viewing-endoscopic vitrectomy using a 3D visualization system

open access: yesClinical Ophthalmology, 2018
Mihori Kita, Yuki Mori, Sachiyo Hama Department of Ophthalmology, National Organization Kyoto Medical Center, Kyoto, Japan Purpose: To introduce a hybrid wide-angle viewing-endoscopic vitrectomy, which we have reported, using a 3D visualization system ...
Kita M, Mori Y, Hama S
doaj  

Proliferative vitreoretinopathy: current and emerging treatments

open access: yesClinical Ophthalmology, 2012
Ama Sadaka,1 Gian Paolo Giuliari2,31Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, MA, USA; 2Centro de Cirugía Oftalmológica (CECOF), Caracas, Venezuela; 3Department of Ophthalmology, Domingo Luciani ...
Sadaka A, Giuliari GP
doaj  

Leveraging AAV1-Rac1T17N to prevent experimental proliferative vitreoretinopathy

open access: yesJournal of Translational Medicine
Background Platelet-derived growth factor receptor β (PDGFRβ) is the principal PDGFR isoform in retinal pigment epithelial (RPE) cells from the epiretinal membranes of patients with proliferative vitreoretinopathy (PVR).
Duo Li   +8 more
doaj   +1 more source

A sustained dual drug delivery system for proliferative vitreoretinopathy

open access: yesDrug Delivery, 2020
Proliferative vitreoretinopathy (PVR) is a significant threat for vision recovery from retinal detachment or ocular trauma. Currently, no approved pharmacological intervention to prevent PVR.
Ying Xiao   +7 more
doaj   +1 more source

Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes [PDF]

open access: yes, 2004
AIM: To evaluate the possibility of translocating autologous peripheral retinal pigment epithelial (RPE) cells and enhance their adhesion to improve functional outcome after choroidal neovascular membrane ...
Baarsma, G.S. (Seerp)   +8 more
core   +3 more sources

The Role of Thrombin in Proliferative Vitreoretinopathy

open access: yesInvestigative Opthalmology & Visual Science, 2014
To determine the role of thrombin in the development of proliferative vitreoretinopathy (PVR).Vitreous was collected from patients undergoing a vitrectomy (macular holes and puckers, n = 11 [controls]; retinal detachment without PVR development following vitrectomy, n = 15 [RRD1]; retinal detachment with PVR development within 6 months after vitrectomy,
Jeroen Bastiaans   +8 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy